Significance of Large Vessel Intracranial Occlusion Causing Acute Ischemic Stroke and TIA
|
|
- Lindsey Palmer
- 5 years ago
- Views:
Transcription
1 Significance of Large Vessel Intracranial Occlusion Causing Acute Ischemic Stroke and TIA Wade S. Smith, MD, PhD; Michael H. Lev, MD, FAHA; Joey D. English, MD, PhD; Erica C. Camargo, MD, MMSc; Maggie Chou; S. Claiborne Johnston, MD, PhD; Gilberto Gonzalez, MD, PhD; Pamela W. Schaefer, MD; William P. Dillon, MD; Walter J. Koroshetz, MD; Karen L. Furie, MD, MPH Background and Purpose Acute ischemic stroke due to large vessel occlusion (LVO) vertebral, basilar, carotid terminus, middle and anterior cerebral arteries likely portends a worse prognosis than stroke unassociated with LVO. Because little prospective angiographic data have been reported on a cohort of unselected patients with stroke and with transient ischemic attack, the clinical impact of LVO has been difficult to quantify. Methods The Screening Technology and Outcome Project in Stroke Study is a prospective imaging-based study of stroke outcomes performed at 2 academic medical centers. Patients with suspected acute stroke who presented within 24 hours of symptom onset and who underwent multimodality CT/CT angiography were approached for consent for collection of clinical data and 6-month assessment of outcome. Demographic and clinical variables and 6-month modified Rankin Scale scores were collected and combined with blinded interpretation of the CT angiography data. The OR of each variable, including occlusion of intracranial vascular segment in predicting good outcome and 6-month mortality, was calculated using univariate and multivariate logistic regression. Results Over a 33-month period, 735 patients with suspected stroke were enrolled. Of these, 578 were adjudicated as stroke and 97 as transient ischemic attack. Among patients with stroke, 267 (46%) had LVO accounting for the stroke and 13 (13%) of patients with transient ischemic attack had LVO accounting for transient ischemic attack symptoms. LVO predicted 6-month mortality (OR, 4.5; 95% CI, 2.7 to 7.3; P 0.001). Six-month good outcome (modified Rankin Scale score 2) was negatively predicted by LVO (0.33; 0.24 to 0.45; P 0.001). Based on multivariate analysis, the presence of basilar and internal carotid terminus occlusions, in addition to National Institutes of Health Stroke Scale and age, independently predicted outcome. Conclusion Large vessel intracranial occlusion accounted for nearly half of acute ischemic strokes in unselected patients presenting to academic medical centers. In addition to age and baseline stroke severity, occlusion of either the basilar or internal carotid terminus segment is an independent predictor of outcome at 6 months. (Stroke. 2009;40: ) Key Words: CT angiography prognosis A clinician treating acute ischemic stroke is best enabled to make clinical decisions if they have good predictive models of clinical outcome considering all data available. Models of clinical outcome after stroke have reported age and stroke severity as independent predictors of clinical outcome. 1 3 It is expected, however, that occlusion of large intracranial vessels such as the basilar artery, carotid terminus, and middle cerebral artery is associated with higher mortality and may also be expected to contribute predictive value to models of stroke outcome. Furthermore, large artery occlusion has been associated with a greater risk of stroke after transient ischemic attack (TIA) and minor stroke. 4 The advent of noninvasive techniques for cerebral angiography (CT angiography and MR angiography) allows for routine acquisition of angiographic information on patients with acute stroke and provides an opportunity to explore the predictive value of vascular status on prognosis. The Screening Technology and Outcome Project in Stroke (STOP Stroke) study was designed in part to prospectively obtain complete head and neck CT angiography on an unselected consecutive cohort of patients with acute stroke and with TIA to better understand the prognostic significance of large vessel occlusion of the intracranial vessels. In this study, we used this information to determine whether acute angio- Received July 6, 2009; final revision received August 13, 2009; accepted September 3, From the Departments of Neurology (W.S.S., J.D.E., S.C.J.) and Radiology (W.P.D.), University of California, San Francisco, Calif; the Departments of Radiology (M.H.L., G.G., P.W.S.) and Neurology (E.C.C., K.L.F.), Massachusetts General Hospital, Boston, Mass; the Department of Neurology (M.C.), Columbia University, New York, NY; and the National Institute of Neurological Disorders and Stroke (W.J.K.), Bethesda, Md. Correspondence to Wade S. Smith, MD, PhD, Professor of Neurology, Department of Neurology, University of California, San Francisco, 505 Parnassus Avenue, San Francisco, CA smithw@neurology.ucsf.edu 2009 American Heart Association, Inc. Stroke is available at DOI: /STROKEAHA
2 Smith et al Significance of Large-Vessel Intracranial Occlusion 3835 Figure 1. Diagnosis of patients in STOP Stroke and prevalence of LVO in patients diagnosed with stroke or TIA. graphic assessment provides significant prognostic information by itself and if this assessment provides additional information beyond that of age and National Institutes of Health Stroke Scale (NIHSS) at the time of patient presentation. Methods The STOP Stroke Study is a prospective imaging-based study of stroke outcomes completed at Massachusetts General Hospital and the University of California San Francisco Medical Center. Patients with suspected acute stroke who presented within 24 hours of symptom onset to the institutions emergency departments and who underwent multimodality CT/CT angiography (CTA) were approached for consent for 6-month follow-up and collection of clinical data. Patients who were transferred to these institutions or had stroke while hospitalized were excluded from the analysis. Both institutions routinely used CT/CTA technology to image all suspected stroke or TIA during the study period unless contraindications to intravenous contrast existed. Surrogate consent was allowed for patients unable to consent for themselves. Patients consented by surrogate were reconsented for follow-up if they had regained capacity. The Institutional Review Boards of both institutions approved this clinical study. Research coordinators for both sites extracted demographic data and data regarding the acute presentation and hospital course and performed 6-month phone follow-up in all patients. All clinical data available through the acute hospitalization, including imaging data, were presented to an independent stroke neurologist who then ascribed the final diagnosis for the patient as stroke, TIA, or not stroke or TIA. Cases categorized as stroke or TIA were subjected to the analysis here (2 cases of pure transient monocular blindness were not considered as TIA in this analysis). Good outcome was defined as a modified Rankin Scale score of 2 measured at 6 months after the stroke. All patients underwent brain CT imaging at 3.25-mm separation, CTA at 1.25-mm increments from the aortic arch through the circle of Willis, and postcontrast CT imaging. CT angiograms were reconstructed as thick maximum intensity projection reconstructions. Both thick maximum intensity projection reconstructions and CT source images were reviewed by 2 neuroradiologists blinded to clinical outcome. Cerebrovascular vessels were divided into segments including supraclinoid internal carotid artery (ICA), first division middle cerebral artery (M1), second division middle cerebral artery (M2), first division anterior cerebral artery (A1), second division anterior cerebral artery (A2), basilar artery (BA), intracranial vertebral artery (VA), first division posterior cerebral artery (P1), and second division posterior cerebral artery (P2). A neuroradiologist determined whether any of these vascular segments was occluded. If this analysis showed no vascular occlusion, the patient was documented as having no large vessel occlusion. If one or more vascular segments were occluded, the case history and NIHSS score were reviewed, and if the vascular occlusion was in the appropriate territory to account for the clinical findings, the case was judged as having a large vessel occlusion; otherwise, if the vascular segment occlusion did not explain the clinical symptoms, the case was classified as not having a large vessel occlusion. Variables tested for prediction of good outcome and mortality included age, gender, ethnicity/race, prior stroke/tia, hypertension, diabetes, atrial fibrillation, coronary artery disease, peripheral vascular disease, hypercholesterolemia, current tobacco use, and presence of segmental vascular occlusion. Use of intravenous tissue plasminogen activator (tpa) or use of endovascular intervention, including intra-arterial (IA) tpa, was not included in the primary model nor were other therapies given during hospitalization because the goal of the model was to best understand prognosis based on initial presenting signs and symptoms. However, analysis of outcomes with and without use of intravenous tpa was performed in a secondary model. Variables were analyzed by univariate and then multivariate modeling using Stata, Version 10 (College Station, Texas). Multivariate modeling included any variable found to have P 0.20 in univariate testing with stepwise elimination by highest probability value and variables retained with P Results Over a 33-month period, 1636 patients were admitted to the study hospitals with presumed stroke or TIA and 741 patients were enrolled in the STOP Stroke study. Of these 741 patients, 5 had missing NIHSS scores, and one was missing a final diagnosis, yielding 735 patients for further analysis (Figure 1). After review of all clinical, laboratory, and clinical data, an independent stroke neurologist determined that 578 patients had stroke (79%), 97 (13%) had TIA, and 60 (8%) did not have either stroke or TIA. Of the 675 patients with stroke/tia, 6-month modified Rankin Scale scores were available in 607. Demographics, risk factors, and stroke classification for the patients with stroke and those with TIA are shown in Table 1. Large vessel occlusion was responsible for 267 (46%) strokes, 13 (13%) TIAs, and 41% of stroke and TIA combined. The locations of vascular occlusion and mean NIHSS score are shown in Table 2. The overall mean NIHSS was 7.6. Patients with small vessel occlusions had a significantly lower NIHSS score than patients with large vessel occlusion (P , Wilcoxon test); the presence of large vessel occlusion was associated with a significant 7.8-point increase in NIHSS score. There was a wide variation in NIHSS scores based on vascular location with carotid terminus and basilar occlusions having the highest NIHSS scores and more distal occlusions (M2, A2, P2) having lower NIHSS scores. Intravenous tpa was given to patients with higher
3 3836 Stroke December 2009 Table 1. Demographics, Vascular Risk Factors, Etiology, and Treatment of Patients With Stroke and Those With TIA Patients with stroke or patients with TIA, N 675 Age, mean SD, years Female 323 (48%) Risk factors Hypertension 415 (62%) Diabetes mellitus 122 (18%) Coronary artery disease 155 (23%) Congestive heart failure 46 (6.8%) Peripheral vascular disease 25 (3.7%) Hyperlipidemia 193 (29%) Smoking 207 (31%) Atrial fibrillation 145 (22%) Baseline Rankin score (71%) 1 78 (12%) 2 51 (7.6%) 3 40 (5.9%) 4 15 (2.2%) 5 4 (0.6%) Not recorded 11 (1.6%) SSS-TOAST stroke etiology Cardioembolic 262 (39%) Large artery 111 (17%) Small vessel 63 (9.4%) Other mechanism 49 (7.3%) Undetermined More than one mechanism 40 (5.9%) Cryptogenic embolic 56 (8.3%) Cryptogenic not embolic 70 (10%) Incomplete workup 23 (3.4%) Missing data 1 (0.1%) Treatment Intravenous tpa 109 (16%) IA treatment 36 (5.3%) Intravenous and IA treatment 18 (2.7%) SSS-TOAST indicates Stop Stroke Study TOAST. NIHSS scores at baseline, but there were no differences in age or vascular distribution in those who did or did not receive intravenous tpa. NIHSS scores showed considerable overlap between patients without large vessel occlusion and those with one, 2, or 3 intracranial vascular segments occluded (Figure 2). The mean scores between each category of large vessel occlusion (shown as a horizontal bar for each category in Figure 2) were significantly higher than scores from patients with a normal CTA (P , Wilcoxon test for each comparison), and the mean scores for 3 vascular segment occlusions was higher than those of single segment occlusions (P 0.018). However, for any particular range of NIHSS scores, there was considerable overlap between patients with a normal and abnormal CT angiogram, suggesting that vascular status may Table 2. NIHSS Scores of Patients With Stroke and Those With TIA at Presentation for Each Location of Vascular Occlusion Vascular Location N (%) NIHSS, Mean SD All patients 675 (100%) Any large vessel 280 (41%) No large vessel 395 (59%) ICA 43 (6.3%) M1 119 (18%) M2 136 (20%) A1 2 (0.3%) A2 7 (1.0%) BA 14 (2.1%) VA 16 (2.4%) P1 8 (1.2%) P2 9 (1.3%) Intravenous tpa 109 (16%) No intravenous tpa 566 (84%) provide additional information to patient prognosis beyond NIHSS alone. To better illustrate this, the presence of large vessel occlusion was compared with the proportion of good outcomes and mortality across various NIHSS strata (Figure 3). Good outcome was significantly influenced within higher ranges of baseline NIHSS scores ( 20), and mortality was marginally influenced for more severe strokes. The specific strata were chosen to allow direct comparison with prior reports of outcomes. 5,6 Clinical outcomes are shown in Table 3 for the overall cohort by demographic, risk factor, and various categories of vascular occlusion. Age, baseline NIHSS score, and gender were strongly predictive of proportion of good outcome and mortality on univariate analysis as were several risk factors. The presence of large vessel occlusion was associated with 4.5-fold increased odds of death (95% CI, 2.7 to 7.3; P 0.001) compared with patients who had a normal CT angiogram. The absence of large vessel occlusion was associated with 3.1-fold increased odds of having a good outcome (95% CI, 2.2 to 4.2; P 0.001) compared with patients with a CTA showing large vessel occlusion (LVO). Vascular segments that were significantly associated with outcome include the ICA, M1, M2, and BA; P1 occlusions correlated with good outcome but not mortality. Only one in 4 patients with ICA or BA occlusions had a good clinical outcome, whereas 34% of M1 and 40% of M2 occlusions had a good outcome. BA occlusions were associated with a 50% mortality followed by ICA occlusion (35%) and M1 and M2 occlusions (24% each). Occlusions of the VA, A1, A2, and P2 segments were not associated with either proportion of good clinical outcome or mortality. To explore the potential independent influence of large vessel occlusion on stroke outcome, all variables available at hospital admission (ie, not including intravenous or IA treatment or intensive care unit-based treatments) with P 0.20 on univariate analysis were tested in a multivariate model to predict good outcome and mortality. These results are shown in Table 3. Younger age, male gender, and lesser
4 Smith et al Significance of Large-Vessel Intracranial Occlusion 3837 Figure 2. Distribution of baseline NIHSS scores for patients with 0, 1, 2, or 3 vascular segments occluded on initial CT angiogram. The horizontal bar indicates the mean of the NIHSS score for each category. stroke severity were positive predictors of good outcome, but occlusion of any particular intracranial vascular segment was not found to predict good outcome independently. ICA and BA in combination did independently predict proportion of good outcomes with an OR of 0.18 (P 0.039). Interaction was identified between baseline NIHSS score and ICA and BA occlusions (but not age or gender) confirming that knowledge of these locations of vascular occlusion is most informative at higher NIHSS scores as suggested by the univariate analysis shown in Figure 2 and Table 2. Age and NIHSS score were strongly predictive of mortality, but no single vascular segment predicted mortality independently when considered in isolation or in combination. Ordinal logistic analysis using 3 modified Rankin Scale outcomes (0 to 2, 3 to 5, 6) found only the presence of LVO predicted outcome (coefficient 2.7, P 0.006) and not age or baseline NIHSS considering the most severe strokes (NIHSS 20), supporting the findings shown in Figure 3. The use of intravenous tpa was associated with good outcome when added to the model in Table 3. Specifically, good outcome was best modeled as age (OR [P]; 0.97 [ 0.001]), NIHSS (0.84 [ 0.001]), female (0.56 [0.002]), and intravenous tpa use (2.0 [0.010]). Intravenous tpa use did not influence mortality. If one explores the influence of LVO in patients who did versus did not receive intravenous tpa, occlusion of the BA and ICA vessels was negatively predictive of good outcome for patients who received intravenous tpa but not in those who were left untreated (Table 4). This analysis is likely confounded by marked differences in baseline NIHSS scores (Table 2) so this analysis should be considered cautiously. Use of IA therapies was so infrequent that this variable was not considered in overall models of outcome. Discussion Large vessel occlusion accounted for 46% of acute strokes in our study. This proportion is likely a reasonable measure of the true burden of large vessel stroke in an urban multiethnic US population because the data were obtained from 2 geographically separate urban centers. Knowledge that a patient has a LVO on acute presentation appears to be important. We found that presence of LVO was associated with a 4.5-fold increased odds of death and a 3-fold reduction in odds of good outcome. Ordered from worse outcome to best, BA, ICA, M1, and M2 occlusions were significantly associated with patient mortality and decreased probability of good outcome. The presence or absence of LVO likely adds independent information about prognosis, especially among patients with more severe strokes. Therefore, angiographic imaging appears to provide an additional independent variable beyond age and baseline NIHSS score to predict patient outcome when considering all information available to the treating physician at patient presentation. Nearly half of all patients with acute stroke and those with TIA in our study were found to have occlusion of at least one intracranial vascular segment. Other studies have found a lower rate based on retrospective reviews of consecutive patients; of 865 consecutive patients with stroke and those with TIA imaged with CTA, 239 (28%) had a LVO 7 and in 133 patients with suspected posterior circulation stroke, 44 (33%) had BA or VA occlusion using CTA. 8 We also observed a LVO rate of 14% for TIA. Patients with TIA with LVO have been found to have a 40% higher rate of second stroke than those with a normal MR angiogram 9 suggesting that these findings on CTA, even for TIA, may be clinically important. This estimate of 28% to 46% large vessel stroke proportion is important when one considers the growing use of endovascular techniques that specifically target these lesions. To properly triage patients to endovascular therapy, patients with LVO need to be rapidly identified. We found that stroke severity alone as measured by the NIHSS appears to be only a modest predictor of LVO as shown in Figure 2. For any
5 3838 Stroke December 2009 Figure 3. Influence of LVO within NIHSS strata on probability of good outcome (A) and mortality (B). particular NIHSS score, the ability to predict occlusion of a single or multiple intracranial vascular segments appears limited, suggesting that the proper triage of patients to endovascular intervention should be informed with noninvasive angiography like CTA. Patient outcomes from large vessel stroke have not been previously measured in a prospective cohort of consecutively imaged patients with standardized assessment of stroke severity and outcome. One retrospective study of 226 consecutive patients undergoing conventional angiography found NIHSS score for various LVO similar to our study in which patients with BA and ICA occlusions had the highest NIHSS scores and M2 occlusions the least. 10 We found a striking dependency of mortality and proportion of good outcomes based on the simple presence or absence of a LVO. The location of the vascular occlusion is important in that ICA, BA, M1, and M2 occlusions were significantly correlated with both mortality and good clinical outcome, whereas more distal occlusions (A2, P2 vessels) were not. At least one conventional angiographic series has shown that a normal angiogram portends a good prognosis, 11 and another retrospective study of stroke outcomes showed that proximal LVO was associated with a more than 7-fold odds of unfavorable outcome. 12 It is well established that BA occlusions are highly morbid as are ICA terminus lesions Our analysis shows that the combination of either BA or ICA occlusion was independently associated with clinical outcome in multivariate analysis likely for strokes with NIHSS score in excess of 19 further suggesting that angiographic status of vessels is informative at the time of hospital presentation. Less information is available about M1 and M2 occlusions, but it has been shown previously that patients with M2 occlusion have lower NIHSS scores than M1 occlusions. 10 The relative impact, however, of one vascular segment occlusion compared with another has not been previously reported and the data reported here may be useful to estimate the prognosis of patients presenting with any particular CTA finding. Previous multivariate models of stroke prognosis that considered variables available at the time of initial evaluation have shown independence of age and baseline neurological examination, 2,16 and age, neurological examination, and baseline imaging (without angiography). 1 We confirmed the finding that age and NIHSS score overpower other clinical characteristics, including vascular risk factors (Table 4). However, our data suggest that angiographic status of intracranial vessels at presentation confers additional prognostic information based on several lines of evidence. First, although NIHSS score and angiographic vascular occlusion are highly correlated, there is significant overlap in NIHSS scores in patients with and without LVO (Figure 2). Because LVO by itself is predictive of outcome, angiographic assessment appears to provide additional information to further refine prognosis in patients with similar age and NIHSS score, specifically at higher stroke severity. Second, clinical trials that have selected patient eligibility by angiography have shown wide variation in NIHSS scale scores despite identical vascular segment occlusions. 5,6 For example, the NIHSS scores ranged from 4 to 30 in Prolyse in Acute Cerebral Thromboembolism (PROACT-II) despite the fact that all patients had documented M1 or M2 occlusion angiographically. 6 Third, we found that the extent of vascular occlusion is related to stroke severity (Figure 2). Lastly, the combination of BA or ICA occlusions alone was found to be an independent predictor of clinical outcome. The patient data included in this model are reflective of academic, urban hospitals that have comprehensive stroke centers (high emphasis on intravenous tpa use and optional endovascular therapy). How reflective these patients are of stroke treatment in general is unclear. We chose to model our outcomes based on the information available at the time a physician needs to make a decision regarding therapy; this includes demographic information, their NIHSS score, and the CTA findings. This model assumes that patients who are considered eligible for intravenous tpa do receive it and that a minority of patients (5.3% in our cohort) do go on to have endovascular treatment. Our model cannot be used to predict how a population of patients who would have been eligible for intravenous tpa would do if not treated because the underlying data were observational. Our models of stroke outcome derived from these data therefore likely underestimate the impact of stroke because 18.5% of our patients
6 Smith et al Significance of Large-Vessel Intracranial Occlusion 3839 Table 3. Univariate and Multivariate Model of Good and Mortal Outcome for Stroke and TIA Good Outcome (mrs 2) Mortality Mean (SD) or N (%) Univariate OR received intravenous or IA or combined intravenous/ia treatment with thrombolytics. However, the database used to create this model approximates a population-based study in that patient eligibility was broad (suspected stroke, 24 hours, multimodality CT/CTA performed) and both hospitals used multimodality CT/CTA as their standard acute imaging protocol in all patients with stroke except those with known renal failure. Because all patients who died were included, but not all patients who survived (or their surrogate) gave Multivariate OR* Mean (SD) or N (%) Univariate OR Multivariate OR All patients 363 (54%) 90 (13%) Age, years 65 (15) 0.96 ( 0.001) 0.97 ( 0.001) 75 (13) 1.04 ( 0.001) 1.03 (0.001) Female 143 (44%) 0.48 ( 0.001) 0.59 (0.002) 54 (17%) 1.76 (0.014) 1.29 (0.320) NIHSS score 4.7 (4.8) 0.86 ( 0.001) 0.86 ( 0.001) 16 (9.2) 1.17 ( 0.001) 1.17 ( 0.001) Risk factors Hypertension 205 (49%) 0.63 (0.004) 0.86 (0.503) 67 (16%) 1.98 (0.007) 1.40 (0.267) Diabetes mellitus 56 (46%) 0.68 (0.055) 0.73 (0.165) 23 (19%) 1.68 (0.049) 1.74 (0.071) Coronary artery disease 75 (48%) 0.76 (0.126) 0.78 (0.270) 30 (19%) 1.84 (0.013) 1.51 (0.154) Congestive heart failure 13 (28%) 0.31 (0.001) 0.78 (0.520) 16 (35%) 4.00 ( 0.001) 1.68 (0.181) Peripheral vascular disease 9 (36%) 0.47 (0.075) 0.59 (0.280) 4 (16%) 1.25 (0.690) 0.83 (0.766) Hyperlipidemia 108 (56%) 1.13 (0.472) 1.23 (0.293) 22 (11%) 0.78 (0.350) 0.73 (0.287) Smoking 131 (63%) 1.75 (0.001) 1.38 (0.101) 21 (10%) 0.65 (0.107) 0.83 (0.545) Atrial fibrillation 57 (39%) 0.47 ( 0.001) 0.92 (0.723) 33 (23%) 2.45 ( 0.001) 1.10 (0.742) Vessels Any large vessel (N 280) 106 (38%) 0.33 ( 0.001) 0.82 (0.364) 65 (23%) 4.47 ( 0.001) 1.42 (0.260) No large vessel (N 363) 257 (65%) 3.06 ( 0.001) 1.21 (0.364) 25 (6.3%) 0.22 ( 0.001) 0.71 (0.260) ICA (N 43) 8 (19%) 0.18 ( 0.001) 0.47 (0.097) 15 (35%) 3.98 ( 0.001) 1.27 (0.557) M1 (N 119) 41 (34%) 0.38 ( 0.001) 0.92 (0.752) 28 (24%) 2.45 ( 0.001) 1.12 (0.701) M2 (N 136) 54 (40%) 0.49 ( 0.001) 1.00 (0.986) 32 (24%) 2.55 ( 0.001) 1.45 (0.187) A1 (N 2) 1 (50%) 0.86 (0.915) 0.40 (0.524) 0 (0%) A2 (N 7) 2 (29%) 0.34 (0.199) 0.81 (0.824) 0 (0%) BA (N 14) 3 (21%) 0.23 (0.024) 0.40 (0.243) 7 (50%) 6.96 ( 0.001) 2.69 (0.175) VA (N 16) 10 (63%) 1.40 (0.481) 1.19 (0.790) 4 (25%) 2.22 (0.175) 3.12 (0.142) P1 (N 8) 1 (13%) 0.12 (0.048) 0.14 (0.084) 2 (25%) 2.19 (0.341) 0.53 (0.663) P2 (N 9) 2 (22%) 0.24 (0.078) 0.34 (0.208) 0 (0%) BA or ICA (N 57) 11 (19%) 0.18 ( 0.001) 0.44 (0.039) 22 (39%) 2.36 ( 0.001) 1.60 (0.215) *Final model included age, gender, and NIHSS score; values shown for other variables are for the individual variable added alone to the final model. Final model included age and NIHSS score; values shown for other variables are for the individual variable added alone to the final model. mrs indicates modified Rankin Scale. Table 4. Influence of Intravenous tpa on Models of Outcome Treatment Good Outcome (mrs 2) Mortality N Age: 0.97 (0.045) NIHSS: 1.08 (0.055) 109 IV tpa: OR (P) NIHSS: 0.89 (0.005) BA or ICA: 0.19 (0.045) Age: 0.97 ( 0.001) Age: 1.04 (0.002) 566 No IV tpa: OR (P) Female: 0.57 (0.005) NIHSS: 1.20 ( 0.001) NIHSS: 0.84 ( 0.001) mrs indicates modified Rankin Scale; IV, intravenous. consent, our follow-up data are likely biased toward more severe strokes. The systematic exclusion of renal failure likely reduced mortality in the study. Because of substantial baseline differences between patients who received thrombolytic therapy and those who did not, like time to presentation, age, and baseline NIHSS, analysis dichotomized by intravenous tpa treatment must be considered with caution. Overall, we feel that this patient sample is reasonably representative of patients with stroke in general who present to urban medical centers. Our data support the use of multimodality imaging of patients with acute stroke and those with TIA because of the added prognostic significance obtained with the data and the high prevalence of LVO in acute stroke and TIA. Additionally, such protocols likely expedite triage to endovascular therapy and expedite the clinical investigation of the stroke mechanism. Knowledge of the intracranial vascular status provides additional, useful information to the treating physician at the time of patient presentation that may improve decision-making.
7 3840 Stroke December 2009 Source of Funding This research was funded by a grant from the Department of Health and Human Services, Agency for Healthcare Research and Quality, grant number RO1- HS A1. Disclosures W.S.S. has significant ownership interests and has served as a consultant to Concentric Medical, Inc (significant). K.L.F. is employed with Massachusetts General Hospital, has received financial support from Deane Institute (both significant), and has served as a consultant to Novartis, Biosante, and GE Healthcare (Modest). W.J.K. has an ownership interest in Neurologica (Modest). There are no other conflicts to report. References 1. Johnston KC, Connors AF Jr, Wagner DP, Knaus WA, Wang X, Haley EC Jr. A predictive risk model for outcomes of ischemic stroke. Stroke. 2000;31: Weimar C, Konig IR, Kraywinkel K, Ziegler A, Diener HC; German Stroke Study Collaboration. Age and National Institutes of Health Stroke Scale Score within 6 hours after onset are accurate predictors of outcome after cerebral ischemia: development and external validation of prognostic models. Stroke. 2004;35: Counsell C, Dennis M, McDowall M, Warlow C. Predicting outcome after acute and subacute stroke: development and validation of new prognostic models. Stroke. 2002;33: Coutts SB, Eliasziw M, Hill MD, Scott JN, Subramaniam S, Buchan AM, Demchuk AM; VISION Study Group. An improved scoring system for identifying patients at high early risk of stroke and functional impairment after an acute transient ischemic attack or minor stroke. Int J Stroke. 2008;3: Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke. 2004;35: Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999;282: Puetz V, Dzialowski I, Coutts SB, Hill MD, Krol A, O Reilly C, Goyal M, Demchuk AM; Calgary CTA Study Group. Frequency and clinical course of stroke and transient ischemic attack patients with intracranial nonocclusive thrombus on computed tomographic angiography. Stroke. 2009;40: Sylaja PN, Puetz V, Dzialowski I, Krol A, Hill MD, Demchuk AM. Prognostic value of CT angiography in patients with suspected vertebrobasilar ischemia. J Neuroimaging. 2008;18: Coutts SB, Hill MD, Campos CR, Choi YB, Subramaniam S, Kosior JC, Demchuk AM; VISION Study Group. Recurrent events in transient ischemic attack and minor stroke: what events are happening and to which patients? Stroke. 2008;39: Fischer U, Arnold M, Nedeltchev K, Brekenfeld C, Ballinari P, Remonda L, Schroth G, Mattle HP. NIHSS score and arteriographic findings in acute ischemic stroke. Stroke. 2005;36: Arnold M, Nedeltchev K, Brekenfeld C, Fischer U, Remonda L, Schroth G, Mattle H. Outcome of acute stroke patients without visible occlusion on early arteriography. Stroke. 2004;35: Nedeltchev K, Schwegler B, Haefeli T, Brekenfeld C, Gralla J, Fischer U, Arnold M, Remonda L, Schroth G, Mattle HP. Outcome of stroke with mild or rapidly improving symptoms. Stroke. 2007;38: Flint AC, Duckwiler GR, Budzik RF, Liebeskind DS, Smith WS: MERCI and Multi MERCI Writing Committee. Mechanical thrombectomy of intracranial internal carotid occlusion: pooled results of the MERCI and Multi MERCI Part I trials. Stroke. 2007;38: Schonewille WJ, Algra A, Serena J, Molina CA, Kappelle LJ. Outcome in patients with basilar artery occlusion treated conventionally. J Neurol Neurosurg Psychiatry. 2005;76: Smith WS. Intra-arterial thrombolytic therapy for acute basilar occlusion: pro. Stroke. 2007;38: Counsell C, Dennis M, McDowall M. Predicting functional outcome in acute stroke: comparison of a simple six variable model with other predictive systems and informal clinical prediction. J Neurol Neurosurg Psychiatry. 2004;75:
The National Institutes of Health Stroke Scale (NIHSS)
National Institutes of Health Stroke Scale Score and Vessel Occlusion in 252 Patients With Acute Ischemic Stroke Mirjam R. Heldner, MD; Christoph Zubler, MD; Heinrich P. Mattle, MD; Gerhard Schroth, MD;
More informationEndovascular stroke treatments are being increasingly used
Published March 18, 2010 as 10.3174/ajnr.A2050 ORIGINAL RESEARCH A.C. Flint S.P. Cullen B.S. Faigeles V.A. Rao Predicting Long-Term Outcome after Endovascular Stroke Treatment: The Totaled Health Risks
More informationThe National Institutes of Health Stroke Scale (NIHSS)
National Institutes of Health Stroke Scale Score and Vessel Occlusion in 2152 Patients With Acute Ischemic Stroke Mirjam R. Heldner, MD; Christoph Zubler, MD; Heinrich P. Mattle, MD; Gerhard Schroth, MD;
More informationTransient ischemic attack (TIA) and minor stroke represent
What Causes Disability After Transient Ischemic Attack and Minor Stroke? Results From the CT And MRI in the Triage of TIA and minor Cerebrovascular Events to Identify High Risk Patients (CATCH) Study Shelagh
More informationMechanical Thrombectomy of Large Vessel Occlusions Using Stent Retriever Devices
Mechanical Thrombectomy of Large Vessel Occlusions Using Stent Retriever Devices Joey English MD, PhD Medical Director, Neurointerventional Services California Pacific Medical Center Hospitals, San Francisco,
More informationRedgrave JN, Coutts SB, Schulz UG et al. Systematic review of associations between the presence of acute ischemic lesions on
6. Imaging in TIA 6.1 What type of brain imaging should be used in suspected TIA? 6.2 Which patients with suspected TIA should be referred for urgent brain imaging? Evidence Tables IMAG1: After TIA/minor
More informationThe DAWN of a New Era for Wake-up Stroke
The DAWN of a New Era for Wake-up Stroke Alan H. Yee, D.O. Stroke and Critical Care Neurology Department of Neurology University of California Davis Medical Center Objectives Review Epidemiology and Natural
More informationStroke Clinical Trials Update Transitioning to an Anatomic Diagnosis in Ischemic Stroke
Stroke Clinical Trials Update Transitioning to an Anatomic Diagnosis in Ischemic Stroke Alexander A. Khalessi MD MS Director of Endovascular Neurosurgery Surgical Director of NeuroCritical Care University
More informationNHL Journal of Medical Sciences/July 2014/Vol 3/Issue 2 18
Research article NIHSS Score: A handy tool to predict vascular occlusion in acute ischemic stroke Ronak Shah*, Chintal Vyas**, Jyoti Vora*** *Senior Resident, **Assistant Professor, ***Associate Professor,
More informationUpdate on Early Acute Ischemic Stroke Interventions
Update on Early Acute Ischemic Stroke Interventions Diana Goodman MD Lead Neurohospitalist Maine Medical Center Assistant Professor of Neurology, Tufts University School of Medicine I have no disclosures
More informationBackground. Recommendations for Imaging of Acute Ischemic Stroke: A Scientific Statement From the American Heart Association
for Imaging of Acute Ischemic Stroke: A Scientific Statement From the American Heart Association An Scientific Statement from the Stroke Council, American Heart Association and American Stroke Association
More informationPerils of Mechanical Thrombectomy in Acute Asymptomatic Large Vessel Occlusion
Perils of Mechanical Thrombectomy in Acute Asymptomatic Large Vessel Occlusion Aman B. Patel, MD Robert & Jean Ojemann Associate Professor Director, Cerebrovascular Surgery Director, Neuroendovascular
More informationComparison of Five Major Recent Endovascular Treatment Trials
Comparison of Five Major Recent Endovascular Treatment Trials Sample size 500 # sites 70 (100 planned) 316 (500 planned) 196 (833 estimated) 206 (690 planned) 16 10 22 39 4 Treatment contrasts Baseline
More informationAlex Abou-Chebl, MD Associate Professor of Neurology and Neurosurgery Director of Neurointerventional Services Director of Vascular and
Alex Abou-Chebl, MD Associate Professor of Neurology and Neurosurgery Director of Neurointerventional Services Director of Vascular and Interventional Neurology Fellowships University of Louisville School
More informationAdvances in the treatment of posterior cerebral circulation symptomatic disease
Advances in the treatment of posterior cerebral circulation symptomatic disease Athanasios D. Giannoukas MD, MSc(Lond.), PhD(Lond.), FEBVS Professor of Vascular Surgery Faculty of Medicine, School of Health
More informationMechanical thrombectomy in Plymouth. Will Adams. Will Adams
Mechanical thrombectomy in Plymouth Will Adams Will Adams History Intra-arterial intervention 1995 (NINDS) iv tpa improved clinical outcome in patients treated within 3 hours of ictus but limited recanalisation
More informationAdvances in Neuro-Endovascular Care for Acute Stroke
Advances in Neuro-Endovascular Care for Acute Stroke Ciarán J. Powers, MD, PhD, FAANS Associate Professor Program Director Department of Neurological Surgery Surgical Director Comprehensive Stroke Center
More informationTIA triage in Not all that glitters is gold
TIA triage in 2016 Not all that glitters is gold Disclosures No industry related disclosures Expert witness work Overview Definition Implications Guidelines, secondary prevention Implementation of guidelines
More informationHistorical. Medical Policy
Medical Policy Subject: Mechanical Embolectomy for Treatment of Acute Stroke Policy #: SURG.00098 Current Effective Date: 01/01/2016 Status: Revised Last Review Date: 08/06/2015 Description/Scope This
More informationStroke Systems of Care
Comprehensive Stroke and Cerebrovascular Center Stroke Systems of Care Dana Stradling RN MSN CNRN UC Irvine Stroke Manager dstradli@uci.edu Why Stroke Systems? No. 4 th 5 th cause of death in the U.S.
More informationSignificant Relationships
Opening Large Vessels During Acute Ischemic Stroke Significant Relationships Wade S Smith, MD, PhD Director UCSF Neurovascular Service Professor of Neurology Daryl R Gress Endowed Chair of Neurocritical
More informationThe Impact of Smoking on Acute Ischemic Stroke
Smoking The Impact of Smoking on Acute Ischemic Stroke Wei-Chieh Weng, M.D. Department of Neurology, Chang-Gung Memorial Hospital, Kee-Lung, Taiwan Smoking related mortality Atherosclerotic vascular disease
More informationACUTE STROKE TREATMENT IN LARGE NIHSS PATIENTS. Justin Nolte, MD Assistant Profession Marshall University School of Medicine
ACUTE STROKE TREATMENT IN LARGE NIHSS PATIENTS Justin Nolte, MD Assistant Profession Marshall University School of Medicine History of Presenting Illness 64 yo wf with PMHx of COPD, HTN, HLP who was in
More informationACUTE STROKE INTERVENTION: THE ROLE OF THROMBECTOMY AND IA LYSIS
Associate Professor of Neurology Director of Neurointerventional Services University of Louisville School of Medicine ACUTE STROKE INTERVENTION: THE ROLE OF THROMBECTOMY AND IA LYSIS Conflict of Interest
More informationDrano vs. MR CLEAN Review of New Endovascular Therapy for Acute Ischemic Stroke Patients
Drano vs. MR CLEAN Review of New Endovascular Therapy for Acute Ischemic Stroke Patients Peter Panagos, MD, FACEP, FAHA Associate Professor Emergency Medicine and Neurology Washington University School
More informationPARADIGM SHIFT FOR THROMBOLYSIS IN PATIENTS WITH ACUTE ISCHAEMIC STROKE, FROM EXTENSION OF THE TIME WINDOW TO RAPID RECANALISATION AFTER SYMPTOM ONSET
PARADIGM SHIFT FOR THROMBOLYSIS IN PATIENTS WITH ACUTE ISCHAEMIC STROKE, FROM EXTENSION OF THE TIME WINDOW TO RAPID RECANALISATION AFTER SYMPTOM ONSET Hye Seon Jeong, *Jei Kim Department of Neurology and
More informationIntra-arterial thrombolysis (IAT) has the potential to rescue
Published September 3, 2008 as 10.3174/ajnr.A1276 ORIGINAL RESEARCH G.A. Christoforidis C. Karakasis Y. Mohammad L.P. Caragine M. Yang A.P. Slivka Predictors of Hemorrhage Following Intra-Arterial Thrombolysis
More informationMichael Horowitz, MD Pittsburgh, PA
Michael Horowitz, MD Pittsburgh, PA Introduction Cervical Artery Dissection occurs by a rupture within the arterial wall leading to an intra-mural Hematoma. A possible consequence is an acute occlusion
More informationACUTE STROKE IMAGING
ACUTE STROKE IMAGING Mahesh V. Jayaraman M.D. Director, Inter ventional Neuroradiology Associate Professor Depar tments of Diagnostic Imaging and Neurosurger y Alper t Medical School at Brown University
More informationSpeakers. 2015, American Heart Association 1
Speakers Lee Schwamm, MD, FAHA Executive Vice Chairman of Neurology, Massachusetts General Hospital Director, Stroke Service and Medical Director, MGH TeleHealth, Massachusetts General Hospital Director,
More informationESCAPE Endovascular treatment for Small Core and Anterior circulation Proximal occlusion with Emphasis on minimizing CT to recanalization times
ESCAPE Endovascular treatment for Small Core and Anterior circulation Proximal occlusion with Emphasis on minimizing CT to recanalization times Michael D Hill, Mayank Goyal on behalf of the ESCAPE Trial
More informationBroadening the Stroke Window in Light of the DAWN Trial
Broadening the Stroke Window in Light of the DAWN Trial South Jersey Neurovascular and Stroke Symposium April 26, 2018 Rohan Chitale, MD Assistant Professor of Neurological Surgery Vanderbilt University
More informationFigures for Draft Response to IMS III, MR RESCUE, and SYNTHSESIS Trials
Figures for Draft Response to IMS III, MR RESCUE, and SYNTHSESIS Trials Figure 1: Lay Press Judgment May Belie a Deeper Examination of the Data. Truman ultimately defeated Dewey for the Presidency Subject
More informationIMAGING IN ACUTE ISCHEMIC STROKE
IMAGING IN ACUTE ISCHEMIC STROKE Timo Krings MD, PhD, FRCP (C) Professor of Radiology & Surgery Braley Chair of Neuroradiology, Chief and Program Director of Diagnostic and Interventional Neuroradiology;
More informationPractical Considerations in the Early Treatment of Acute Stroke
Practical Considerations in the Early Treatment of Acute Stroke Matthew E. Fink, MD Neurologist-in-Chief Weill Cornell Medical College New York-Presbyterian Hospital mfink@med.cornell.edu Disclosures Consultant
More informationCOMPREHENSIVE SUMMARY OF INSTOR REPORTS
COMPREHENSIVE SUMMARY OF INSTOR REPORTS Please note that the following chart provides a sampling of INSTOR reports to differentiate this registry s capabilities as a process improvement system. This list
More informationClinical Study Circle of Willis Variants: Fetal PCA
Stroke Research and Treatment Volume 2013, Article ID 105937, 6 pages http://dx.doi.org/10.1155/2013/105937 Clinical Study Circle of Willis Variants: Fetal PCA Amir Shaban, 1 Karen C. Albright, 2,3,4,5
More informationDownloaded from by on January 15, 2019
Alberta Stroke Program Early Computed Tomography Score to Select Patients for Endovascular Treatment Interventional Management of Stroke (IMS)-III Trial Michael D. Hill, MD, FRCPC; Andrew M. Demchuk, MD,
More informationUPDATES IN INTRACRANIAL INTERVENTION Jordan Taylor DO Metro Health Neurology 2015
UPDATES IN INTRACRANIAL INTERVENTION Jordan Taylor DO Metro Health Neurology 2015 NEW STUDIES FOR 2015 MR CLEAN ESCAPE EXTEND-IA REVASCAT SWIFT PRIME RECOGNIZED LIMITATIONS IV Alteplase proven benefit
More informationThe Effect of Diagnostic Catheter Angiography on Outcomes of Acute Ischemic Stroke Patients Being Considered for Endovascular Treatment
The Effect of Diagnostic Catheter Angiography on Outcomes of Acute Ischemic Stroke Patients Being Considered for Endovascular Treatment Adnan I. Qureshi, MD 1, Muhammad A. Saleem, MD 1, Emrah Aytaç, MD
More informationCryptogenic Strokes: Evaluation and Management
Cryptogenic Strokes: Evaluation and Management 77 yo man with hypertension and hyperlipidemia developed onset of left hemiparesis and right gaze preference, last seen normal at 10:00 AM Brought to ZSFG
More informationDisclosures. An Update on TIA and Minor Stroke. The Agenda PROGNOSIS PATHOPHYSIOLOGY GUIDELINES AND PROVEN MANAGEMENT STRATEGIES AGGRESSIVE TREATMENT
Disclosures An Update on TIA and Minor Stroke Dr. Johnston is principal investigator for the POINT trial, sponsored by the NIH but with drug and placebo contributed by Sanofi-Aventis. S. Claiborne Johnston,
More informationSpontaneous Recanalization after Complete Occlusion of the Common Carotid Artery with Subsequent Embolic Ischemic Stroke
Original Contribution Spontaneous Recanalization after Complete Occlusion of the Common Carotid Artery with Subsequent Embolic Ischemic Stroke Abstract Introduction: Acute carotid artery occlusion carries
More informationOpen Access The Addition of MRI to CT Based Stroke and TIA Evaluation Does Not Impact One year Outcomes
Send Orders of Reprints at reprints@benthamscience.net The Open Neurology Journal, 2013, 7, 17-22 17 Open Access The Addition of MRI to CT Based Stroke and TIA Evaluation Does Not Impact One year Outcomes
More informationStrokecenter Key lessons of MR CLEAN study
Strokecenter Key lessons of MR CLEAN study Diederik Dippel Disclosures Funded by the Dutch Heart Foundation Nominal, unrestricted grants from AngioCare BV Medtronic/Covidien/EV3 MEDAC Gmbh/LAMEPRO Penumbra
More informationEndovascular Treatment Updates in Stroke Care
Endovascular Treatment Updates in Stroke Care Autumn Graham, MD April 6-10, 2017 Phoenix, AZ Endovascular Treatment Updates in Stroke Care Autumn Graham, MD Associate Professor of Clinical Emergency Medicine
More informationHow to Interpret CT/CTA for Acute Stroke in the Age of Endovascular Clot Retrieval
How to Interpret CT/CTA for Acute Stroke in the Age of Endovascular Clot Retrieval Peter Howard MD FRCPC Disclosures No conflicts to disclose How to Interpret CT/CTA for Acute Stroke in the Age of Endovascular
More informationStroke is the third-leading cause of death and a major
Long-Term Mortality and Recurrent Stroke Risk Among Chinese Stroke Patients With Predominant Intracranial Atherosclerosis Ka Sing Wong, MD; Huan Li, MD Background and Purpose The goal of this study was
More informationIschemic Stroke in Critically Ill Patients with Malignancy
Ischemic Stroke in Critically Ill Patients with Malignancy Jeong-Am Ryu 1, Oh Young Bang 2, Daesang Lee 1, Jinkyeong Park 1, Jeong Hoon Yang 1, Gee Young Suh 1, Joongbum Cho 1, Chi Ryang Chung 1, Chi-Min
More informationNew therapies directed at acute middle cerebral artery
Regional Angiographic Grading System for Collateral Flow Correlation With Cerebral Infarction in Patients With Middle Cerebral Artery Occlusion Jane J. Kim, MD; Nancy J. Fischbein, MD; Ying Lu, PhD; Daniel
More informationThe term minor stroke is often used for stroke patients
What Is a Minor Stroke? Urs Fischer, MD, MSc; Adrian Baumgartner, MS; Marcel Arnold, MD; Krassen Nedeltchev, MD; Jan Gralla, MD, MSc; Gian Marco De Marchis, MD; Liliane Kappeler, MD; Marie-Luise Mono,
More informationIMAGING IN ACUTE ISCHEMIC STROKE
IMAGING IN ACUTE ISCHEMIC STROKE Timo Krings MD, PhD, FRCP (C) Professor of Radiology & Surgery Braley Chair of Neuroradiology, Chief and Program Director of Diagnostic and Interventional Neuroradiology;
More informationImaging Stroke: Is There a Stroke Equivalent of the ECG? Albert J. Yoo, MD Director of Acute Stroke Intervention Massachusetts General Hospital
Imaging Stroke: Is There a Stroke Equivalent of the ECG? Albert J. Yoo, MD Director of Acute Stroke Intervention Massachusetts General Hospital Disclosures Penumbra, Inc. research grant (significant) for
More informationEndovascular Neurointervention in Cerebral Ischemia
Endovascular Neurointervention in Cerebral Ischemia Beyond Thrombolytics Curtis A. Given II, MD Co-Director, Neurointerventional Services Baptist Physician Lexington 72 y/o female with a recent diagnosis
More informationMechanical thrombectomy beyond the 6 hours. Mahmoud Rayes, MD Medical Director, Stroke program Greenville Memorial Hospital
Mechanical thrombectomy beyond the 6 hours Mahmoud Rayes, MD Medical Director, Stroke program Greenville Memorial Hospital Disclosures None Worldwide statistics 1 IN 6 people will have a stroke at some
More informationStroke Update. Lacunar 19% Thromboembolic 6% SAH 13% ICH 13% Unknown 32% Hemorrhagic 26% Ischemic 71% Other 3% Cardioembolic 14%
Stroke Update Michel Torbey, MD, MPH, FAHA, FNCS Medical Director, Neurovascular Stroke Center Professor Department of Neurology and Neurosurgery The Ohio State University Wexner Medical Center Objectives
More informationImproved Outcome Prediction Using CT Angiography in Addition to Standard Ischemic Stroke Assessment: Results from the STOPStroke Study
Improved Outcome Prediction Using CT Angiography in Addition to Standard Ischemic Stroke Assessment: Results from the STOPStroke Study The Harvard community has made this article openly available. Please
More informationIntravenous tpa has been a mainstay of acute stroke
J Neurosurg 115:359 363, 2011 Aggressive intervention to treat a young woman with intracranial hemorrhage following unsuccessful intravenous thrombolysis for left middle cerebral artery occlusion Case
More informationCode Stroke Intervention: Endovascular Therapies for Stroke J. DIEGO LOZANO MD INTERVENTIONAL NEURORADIOLOGY
Code Stroke Intervention: Endovascular Therapies for Stroke J. DIEGO LOZANO MD INTERVENTIONAL NEURORADIOLOGY Disclosures None Part A. Objectives Epidemiology of AIS and of ELVO Concept: Acute Ischemic
More informationClinical Features and Subtypes of Ischemic Stroke Associated with Peripheral Arterial Disease
Cronicon OPEN ACCESS EC NEUROLOGY Research Article Clinical Features and Subtypes of Ischemic Stroke Associated with Peripheral Arterial Disease Jin Ok Kim, Hyung-IL Kim, Jae Guk Kim, Hanna Choi, Sung-Yeon
More informationEndovascular Treatment for Acute Ischemic Stroke
ular Treatment for Acute Ischemic Stroke Vishal B. Jani MD Assistant Professor Interventional Neurology, Division of Department of Neurology. Creighton University/ CHI health Omaha NE Disclosure None 1
More informationEndovascular Treatment of Ischemic Stroke
Endovascular Treatment of Ischemic Stroke William Thorell, MD Associate Professor Neurosurgery UNMC Co-Director Stroke and Neurovascular Center Nebraska Medicine Overview Definitions of terms Review basic
More informationReduction of flow velocities in patients with ischemic events in the middle cerebral artery long-term follow-up with ultrasound
Acta Neurol. Belg., 20,, -5 Original articles Reduction of flow velocities in patients with ischemic events in the middle cerebral artery long-term follow-up with ultrasound Christine Kremer and Kasim
More informationIntra-arterial thrombolysis has improved the prognosis of
Mechanical Thrombectomy for Acute Ischemic Stroke Thrombus Device Interaction, Efficiency, and Complications In Vivo Jan Gralla, MD; Gerhard Schroth, MD; Luca Remonda, MD; Krassen Nedeltchev, MD; Johannes
More informationBY MARILYN M. RYMER, MD
Lytics, Devices, and Advanced Imaging The evolving art and science of acute stroke intervention. BY MARILYN M. RYMER, MD In 1996, when the US Food and Drug Administration (FDA) approved the use of intravenous
More informationPFO Management update
PFO Management update May 12, 2017 Peter Casterella, MD Swedish Heart and Vascular 1 PFO Update 2017: Objectives Review recently released late outcomes of RESPECT trial and subsequent FDA approval of PFO
More informationVivek R. Deshmukh, MD Director, Cerebrovascular and Endovascular Neurosurgery Chairman, Department of Neurosurgery Providence Brain and Spine
Vivek R. Deshmukh, MD Director, Cerebrovascular and Endovascular Neurosurgery Chairman, Department of Neurosurgery Providence Brain and Spine Institute The Oregon Clinic Disclosure I declare that neither
More informationNeurologic Examination at 24 to 48 Hours Predicts Functional Outcomes in Basilar Artery Occlusion Stroke
Neurologic Examination at 24 to 48 Hours Predicts Functional Outcomes in Basilar Artery Occlusion Stroke Srikant Rangaraju, Emory University Tudor G. Jovin, University of Pittsburgh Michael Frankel, Emory
More informationAcute basilar artery occlusion (BAO) is associated with a very
ORIGINAL RESEARCH INTERVENTIONAL Acute Basilar Artery Occlusion: Outcome of Mechanical Thrombectomy with Solitaire Stent within 8 Hours of Stroke Onset J.M. Baek, W. Yoon, S.K. Kim, M.Y. Jung, M.S. Park,
More informationParameter Optimized Treatment for Acute Ischemic Stroke
Heart & Stroke Barnett Memorial Lectureship and Visiting Professorship Parameter Optimized Treatment for Acute Ischemic Stroke December 2, 2016, Thunder Bay, Ontario Adnan I. Qureshi MD Professor of Neurology,
More informationAcute Stroke Treatment: Current Trends 2010
Acute Stroke Treatment: Current Trends 2010 Helmi L. Lutsep, MD Oregon Stroke Center Oregon Health & Science University Overview Ischemic Stroke Neuroprotectant trials to watch for IV tpa longer treatment
More informationORIGINAL CONTRIBUTION. Early Stroke Risk After Transient Ischemic Attack Among Individuals With Symptomatic Intracranial Artery Stenosis
ORIGINAL CONTRIBUTION Early Stroke Risk After Transient Ischemic Attack Among Individuals With Symptomatic Intracranial Artery Stenosis Bruce Ovbiagele, MD; Salvador Cruz-Flores, MD; Michael J. Lynn, MS;
More informationIn cerebral infarction, the prognostic value of angiographic
Nonrelevant Cerebral Atherosclerosis is a Strong Prognostic Factor in Acute Cerebral Infarction Jinkwon Kim, MD; Tae-Jin Song, MD; Dongbeom Song, MD; Hye Sun Lee, MS; Chung Mo Nam, PhD; Hyo Suk Nam, MD,
More informationStroke Treatment Beyond Traditional Time Windows. Rishi Gupta, MD, MBA
Stroke Treatment Beyond Traditional Time Windows Rishi Gupta, MD, MBA Director, Stroke and Neurocritical Care Endovascular Neurosurgery Wellstar Health System THE PAST THE PRESENT 2015 American Heart Association/American
More informationLittle is known about the proportion of acute ischemic strokes
ORIGINAL RESEARCH ADULT BRAIN Whole-Brain Susceptibility-Weighted Thrombus Imaging in Stroke: Fragmented Thrombi Predict Worse Outcome P.P. Gratz, G. Schroth, J. Gralla, H.P. Mattle, U. Fischer, S. Jung,
More informationOverview. International Stroke Conference Update Clot buster use rises most among 80 and older stroke patients ACUTE STROKE 2/13/2015
Overview International Stroke Conference Update 2015 Nerissa U. Ko, MD, MAS University of California, San Francisco Recent Advances in Neurology February 13, 2015 Nothing to disclose Non-endovascular treatment
More informationSince the National Institute of Neurologic Disorders and
ORIGINAL RESEARCH R.M. Sugg E.A. Noser H.M. Shaltoni N.R. Gonzales M.S. Campbell R. Weir E.D. Cacayorin J.C. Grotta Intra-Arterial Reteplase Compared to Urokinase for Thrombolytic Recanalization in Acute
More informationCurrent treatment options for acute ischemic stroke include
ORIGINAL RESEARCH M.-N. Psychogios A. Kreusch K. Wasser A. Mohr K. Gröschel M. Knauth Recanalization of Large Intracranial Vessels Using the Penumbra System: A Single-Center Experience BACKGROUND AND PURPOSE:
More informationExtra- and intracranial tandem occlusions in the anterior circulation - clinical outcome of endovascular treatment in acute major stroke.
Extra- and intracranial tandem occlusions in the anterior circulation - clinical outcome of endovascular treatment in acute major stroke. Poster No.: C-1669 Congress: ECR 2014 Type: Scientific Exhibit
More informationACUTE ISCHEMIC STROKE. Current Treatment Approaches for Acute Ischemic Stroke
ACUTE ISCHEMIC STROKE Current Treatment Approaches for Acute Ischemic Stroke EARLY MANAGEMENT OF ACUTE ISCHEMIC STROKE Rapid identification of a stroke Immediate EMS transport to nearest stroke center
More informationThe prognosis for acute basilar artery occlusion (BAO) is
Published July 17, 2014 as 10.3174/ajnr.A4045 ORIGINAL RESEARCH INTERVENTIONAL Forced Arterial Suction Thrombectomy with the Penumbra Reperfusion Catheter in Acute Basilar Artery Occlusion: A Retrospective
More informationAcute brain MRI DWI patterns and stroke recurrence after mild-moderate stroke
J Neurol (2010) 257:947 953 DOI 10.1007/s00415-009-5443-5 ORIGINAL COMMUNICATION Acute brain MRI DWI patterns and stroke recurrence after mild-moderate stroke Jaume Roquer A. Rodríguez-Campello E. Cuadrado-Godia
More informationBasilar artery stenosis with bilateral cerebellar strokes on coumadin
Qaisar A. Shah, MD Patient Profile 68 years old female with a history of; Basilar artery stenosis with bilateral cerebellar strokes on coumadin Diabetes mellitus Hyperlipidemia Hypertension She developed
More informationCanadian Best Practice Recommendations for Stroke Care. (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management
Canadian Best Practice Recommendations for Stroke Care (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management Reorganization of Recommendations 2008 2006 RECOMMENDATIONS: 2008 RECOMMENDATIONS:
More informationAcute Stroke Identification and Treatment
Acute Stroke Identification and Treatment James S. McKinney, MD, FAHA Medical Director, NHRMC Stroke Center SE NC is located in the buckle of the Stroke Belt, seeing the highest stroke incidence and mortality
More informationMechanical Thrombectomy Using a Solitaire Stent in Acute Ischemic Stroke; Initial Experience in 40 Patients
Journal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2012.14.3.164 Original Article Mechanical Thrombectomy Using a Solitaire Stent in
More informationDisclosure. Advances in Interventional Neurology. Disclosure. Natural History of Disease 3/15/2018. Vishal B. Jani MD
Advances in Interventional Neurology Disclosure Vishal B. Jani MD Medical Director Vascular Neurology Consultant Interventional Neurology CHI Health Assistant Professor, Creighton University School of
More informationMechanical endovascular thrombectomy for acute ischemic stroke: a retrospective multicenter study in Belgium
DOI 10.1007/s13760-015-0552-7 ORIGINAL ARTICLE Mechanical endovascular thrombectomy for acute ischemic stroke: a retrospective multicenter study in Belgium Niels Fockaert 1 Marieke Coninckx 2 Sam Heye
More informationPublished April 17, 2014 as /ajnr.A3931
Published April 17, 2014 as 10.3174/ajnr.A3931 ORIGINAL RESEARCH BRAIN Relative Filling Time Delay Based on CT Perfusion Source Imaging: A Simple Method to Predict Outcome in Acute Ischemic Stroke W. Cao,
More informationThe hyperdense vessel sign on CT predicts successful recanalization with the Merci device in acute ischemic stroke
Editor s choice Scan to access more free content 1 Neuro Interventional Service, University of Iowa, Carver College of Medicine, Iowa City, Iowa, USA 2 Division of Interventional Neuroradiology, UCLA,
More information[(PHY-3a) Initials of MD reviewing films] [(PHY-3b) Initials of 2 nd opinion MD]
2015 PHYSICIAN SIGN-OFF (1) STUDY NO (PHY-1) CASE, PER PHYSICIAN REVIEW 1=yes 2=no [strictly meets case definition] (PHY-1a) CASE, IN PHYSICIAN S OPINION 1=yes 2=no (PHY-2) (PHY-3) [based on all available
More informationArterial Occlusion Revealed by CT Angiography Predicts NIH Stroke Score and Acute Outcomes after IV tpa Treatment
AJNR Am J Neuroradiol 26:246 251, February 2005 Arterial Occlusion Revealed by CT Angiography Predicts NIH Stroke Score and Acute Outcomes after IV tpa Treatment John R. Sims, Guy Rordorf, Eric E. Smith,
More informationAcute brain vessel thrombectomie: when? Why? How?
Acute brain vessel thrombectomie: when? Why? How? Didier Payen, MD, Ph D Université Paris 7 Département Anesthesiologie-Réanimation Univ Paris 7; Unité INSERM 1160 Hôpital Lariboisière AP-HParis current
More informationENDOVASCULAR THERAPIES FOR ACUTE STROKE
ENDOVASCULAR THERAPIES FOR ACUTE STROKE Cerebral Arteriogram Cerebral Anatomy Cerebral Anatomy Brain Imaging Acute Ischemic Stroke (AIS) Therapy Main goal is to restore blood flow and improve perfusion
More informationDISCLOSURES. Learning Objectives. David Lee Gordon, MD, FAHA Update in Stroke 2007 FINANCIAL DISCLOSURE UNLABELED/UNAPPROVED USES DISCLOSURE
Acute Stroke Care and the Role of EMS Ryan Hakimi, DO, MS April 30, 2015 Assistant Professor Director, Critical Care Neurology Department of Neurology University of Oklahoma Health Sciences Center DISCLOSURES
More information12/4/2017. Disclosures. Study organization. Stryker Medtronic Penumbra Viz Route 92. Data safety monitoring board Tudor G.
12/4/2017 Update on Stroke Trials:Extending the Window DWI or CTP Assessment with Clinical Mismatch in the Triage of Wake-Up and Late Presenting Strokes Undergoing Neurointervention with Trevo NP001713
More informationPrognostic Value of the Hyperdense Middle Cerebral Artery Sign and Stroke Scale Score before Ultraearly Thrombolytic Therapy
Prognostic Value of the Hyperdense Middle Cerebral Artery Sign and Stroke Scale Score before Ultraearly Thrombolytic Therapy Thomas Tomsick, Thomas Brott, William Barsan, Joseph Broderick, E. Clarke Haley,
More informationNon-commercial use only
Italian Journal of Medicine 2016; volume 10:202-206 Embolic stroke of undetermined source: a retrospective analysis from an Italian Stroke Unit Marco Masina, 1 Annalena Cicognani, 1 Carla Lofiego, 2 Simona
More information